X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2706) 2706
Publication (241) 241
Patent (113) 113
Conference Proceeding (99) 99
Book Review (18) 18
Book / eBook (12) 12
Book Chapter (12) 12
Magazine Article (10) 10
Dissertation (8) 8
Newspaper Article (7) 7
Paper (5) 5
Data Set (2) 2
Reference (2) 2
Technical Report (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (909) 909
index medicus (725) 725
female (704) 704
male (512) 512
oncology (507) 507
middle aged (504) 504
aged (446) 446
adult (431) 431
animals (271) 271
cancer (239) 239
treatment outcome (187) 187
chemotherapy (175) 175
surgery (165) 165
analysis (154) 154
aged, 80 and over (153) 153
medicine & public health (147) 147
pharmacology & pharmacy (143) 143
care and treatment (129) 129
research (125) 125
antineoplastic combined chemotherapy protocols - therapeutic use (110) 110
neoplasms - drug therapy (108) 108
retrospective studies (103) 103
cardiac & cardiovascular systems (102) 102
tumors (99) 99
carcinoma (97) 97
obstetrics & gynecology (94) 94
therapy (93) 93
italy (91) 91
survival (90) 90
ovarian cancer (87) 87
hematology, oncology and palliative medicine (86) 86
antineoplastic agents - therapeutic use (84) 84
trial (84) 84
chemistry (80) 80
dose-response relationship, drug (77) 77
metastasis (75) 75
adolescent (73) 73
antineoplastic combined chemotherapy protocols - adverse effects (73) 73
health aspects (73) 73
patients (73) 73
pharmacology/toxicology (73) 73
risk factors (72) 72
physics, nuclear (71) 71
clinical trials (70) 70
breast cancer (69) 69
physics (69) 69
antineoplastic agents - adverse effects (68) 68
drug therapy (67) 67
human necessities (67) 67
neoplasm staging (67) 67
pharmacokinetics (65) 65
metallurgy (64) 64
organic chemistry (64) 64
young adult (63) 63
article (62) 62
follow-up studies (62) 62
management (62) 62
neurosciences (62) 62
time factors (62) 62
agriculture (60) 60
animal husbandry (60) 60
drug administration schedule (60) 60
forestry (60) 60
physics, applied (60) 60
solid tumors (60) 60
fishing (59) 59
hunting (59) 59
prognosis (59) 59
trapping (59) 59
antineoplastic agents - administration & dosage (58) 58
biocides, e.g. as disinfectants, as pesticides, as herbicides (58) 58
heterocyclic compounds (58) 58
mice (58) 58
pest repellants or attractants (58) 58
plant growth regulators (58) 58
preservation of bodies of humans or animals or plants or partsthereof (58) 58
diagnosis (57) 57
maximum tolerated dose (57) 57
child (56) 56
clinical neurology (56) 56
expression (56) 56
cells (54) 54
prospective studies (54) 54
rats (52) 52
breast neoplasms - drug therapy (51) 51
disease-free survival (51) 51
materials science, multidisciplinary (51) 51
paclitaxel (51) 51
respiratory system (51) 51
biochemistry & molecular biology (50) 50
ovarian neoplasms - drug therapy (50) 50
cattle (49) 49
cell biology (49) 49
medical research (49) 49
studies (49) 49
women (49) 49
medicine (48) 48
nuclear science & technology (48) 48
cisplatin (47) 47
antineoplastic agents - pharmacokinetics (46) 46
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (5) 5
Collection Dvlpm't (Acquisitions) - Shipping from publisher (1) 1
Gerstein Science - Stacks (1) 1
Robarts - Storage (1) 1
St. Michael's College (John M. Kelly) - 3rd Floor (1) 1
UTL at Downsview - May be requested (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2728) 2728
Italian (125) 125
French (69) 69
German (34) 34
Japanese (13) 13
Portuguese (7) 7
Spanish (7) 7
Norwegian (4) 4
Arabic (2) 2
Chinese (2) 2
Romanian (2) 2
Greek (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 10, pp. 1011 - 1019
Journal Article
by Coleman, Robert L and Coleman, R L and Oza, Amit M and Oza, A M and Lorusso, D and Lorusso, Domenica and Aghajanian, C and Aghajanian, Carol and Oaknin, A and Oaknin, Ana and Dean, A and Dean, Andrew and Colombo, N and Colombo, Nicoletta and Weberpals, Johanne I and Weberpals, J I and Clamp, Andrew and Clamp, A and Scambia, Giovanni and Scambia, G and Leary, A and Leary, Alexandra and Holloway, Robert W and Holloway, R W and Gancedo, M Amenedo and Gancedo, Margarita Amenedo and Fong, Peter C and Fong, P C and Goh, Jeffrey C and Goh, J C and O'Malley, David M and O'Malley, D M and Armstrong, Deborah K and Armstrong, D K and Garcia-Donas, Jesus and Garcia-Donas, J and Swisher, E M and Swisher, Elizabeth M and Floquet, A and Floquet, Anne and Konecny, Gottfried E and Konecny, G E and McNeish, I A and McNeish, Iain A and Scott, C L and Scott, Clare L and Cameron, Terri and Maloney, Lara and Isaacson, Jeff and Goble, Sandra and Grace, Caroline and Harding, Thomas C and Raponi, Mitch and Sun, James and Lin, Kevin K and Giordano, Heidi and Ledermann, J A and Ledermann, Jonathan A and Buck, M and Friedlander, M L and Harnett, P and Kichenadasse, G and Denys, H and Dirix, L and Vergote, I and Elit, L and Ghatage, P and Plante, M and Provencher, D and Welch, S and Gladieff, L and Joly, F and Lortholary, A and Lotz, J and Medioni, J and Tredan, O and You, B and El-Balat, A and Hänle, C and Krabisch, P and Neunhöffer, T and Pölcher, M and Wimberger, P and Amit, A and Kovel, S and Leviov, M and Safra, T and Shapira-Frommer, R and Stemmer, S and Bologna, A and Pignata, S and Sabbatini, R F and Tamberi, S and Zamagni, C and O'Donnell, A and Herraez, A Casado and Guerra, E M and Palacio, I and Romero, I and Sanchez, A and ... and ARIEL3 Investigators and ARIEL3 investigators
The Lancet, ISSN 0140-6736, 10/2017, Volume 390, Issue 10106, pp. 1949 - 1961
Rucaparib, a poly(ADP-ribose) polymerase inhibitor, has anticancer activity in recurrent ovarian carcinoma harbouring a mutation or high percentage of... 
MEDICINE, GENERAL & INTERNAL | MULTICENTER | SOLID TUMORS | BEVACIZUMAB | OPEN-LABEL | CANCER | HETEROZYGOSITY | EPITHELIAL OVARIAN | CHEMOTHERAPY | Double-Blind Method | Follow-Up Studies | Risk Assessment | Humans | Middle Aged | Ovarian Neoplasms - pathology | Neoplasm Recurrence, Local - drug therapy | Survival Rate | Treatment Outcome | Ovarian Neoplasms - mortality | Neoplasm Recurrence, Local - mortality | Indoles - administration & dosage | Poly(ADP-ribose) Polymerase Inhibitors - administration & dosage | Neoplasm Recurrence, Local - pathology | Disease-Free Survival | Maintenance Chemotherapy - methods | Internationality | Ovarian Neoplasms - therapy | Female | Aged | Molecular Targeted Therapy - methods | Clinical trials | Care and treatment | Carcinoma | Drug therapy | Ovarian cancer | Cancer | Analysis | Chemotherapy | Ovarian carcinoma | Platinum | Biomarkers | Mutation | Cancer therapies | Tumors | Homologous recombination | Central nervous system | Poly(ADP-ribose) | Homology | Genomes | Fallopian tube | ADP | Anticancer properties | Metastases | Homologous recombination repair | Randomization | Pain | Motivation | Ribose | Hemoglobin | Alanine | Anemia | Poly(ADP-ribose) polymerase | Breast cancer | Patients | Survival | Heterozygosity | Abdomen | Polymerase | Inhibitors | Point mutation | Loss of heterozygosity | Antitumor activity | Aspartate aminotransferase | Peritoneum
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 4, pp. 396 - 405
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 5, pp. 561 - 568
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 8, pp. 1137 - 1146
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 11, pp. 1077 - 1085
Journal Article
Annals of Thoracic Surgery, ISSN 0003-4975, 2016, Volume 101, Issue 3, pp. 919 - 926
Journal Article
Journal of Thoracic and Cardiovascular Surgery, The, ISSN 0022-5223, 2013, Volume 145, Issue 1, pp. 128 - 139
Journal Article
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, ISSN 1570-0232, 4/2012, pp. 64 - 70
A liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) assay was developed and validated for simultaneously determination of... 
pharmacokinetics | mass spectrometry | high performance liquid chromatography | LC-MS | FAU | FMAU
Journal Article
by Fox, K.M and Bertrand, M and Ferrari, R and Remme, W.J and Simoons, M.L and Simoons, M and Bassand, J.P and Aldershvile, J and Hildebrandt, P and Cokkinos, D and Toutouzas, P and Eha, J and Erhardt, L and Erikssen, J and Grybauskas, P and Kalnins, U and Karsch, K and Sechtem, U and Keltai, M and Klein, W and Lüscher, T and Mulcahy, D and Nieminen, M and Oto, A and Ozsaruhan, O and Paulus, W and Providencia, L and Riecansky, I and Ruzyllo, W and Santini, U and Tavazzi, L and Soler-Soler, J and Widimsky, P and Julian, D and Dargie, H and Murray, G and Kübler, W and Thygesen, K and Duprez, D and Steg, G and Drexel, H and Gombotz, G and Duprez, D and Heyndrickx, G.H and Legrand, V and Materne, P and Van Mieghem, W and Bocek, P and Branny, M and Cech, M and Charouzek, J and Drazka, J and Fabik, L and Florian, J and Francek, L and Groch, L and Havranek, P and Hradec, J and Jansky, P and Jirmar, R and Jokl, I and Krejcova, H and Kvasnak, M and Maratka, T and Marcinek, G and Moravcova, J and Nedbal, P and Peterka, K and Povolny, J and Rosolova, H and Semrad, B and Sochor, K and Spacek, R and Spinar, J and Stipal, R and Stuchlik, K and Sulda, M and Ulman, J and Vaclavicek, A and Vojtisek, P and Bjerregaard-Andersen, H and Hildebrandt, P and Kristensen, K and Madsen, J.K and Markenvard, J and Meibom, J and Norgaard, A and Scheibel, M and Eha, J and Leht, A and Teesalu, R and Vahula, V and Itkonen, A and Juvonen, J and Karmakoski, J and Kilkki, E and Koskela, E and Melin, J and Nieminen, M.S and Savola, R and ... and EURopean Trial Reduction Cardiac E and EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators
The Lancet, ISSN 0140-6736, 09/2003, Volume 362, Issue 9386, pp. 782 - 788
Treatment with angiotensin-converting-enzyme (ACE) inhibitors reduces the rate of cardiovascular events among patients with left-ventricular dysfunction and... 
SURVIVAL | MEDICINE, GENERAL & INTERNAL | ACE | LEFT-VENTRICULAR DYSFUNCTION | MYOCARDIAL-INFARCTION | HYPERTENSION | EXPRESSION | CONVERTING-ENZYME-INHIBITORS | BLOOD-PRESSURE | CAPTOPRIL | Double-Blind Method | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Treatment Outcome | Cause of Death | Coronary Disease - mortality | Heart Failure - prevention & control | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Heart Arrest - prevention & control | Cardiovascular Diseases - mortality | Coronary Disease - drug therapy | Female | Myocardial Infarction - prevention & control | Perindopril - therapeutic use | Evaluation | Drug therapy | ACE inhibitors | Coronary heart disease | Cardiovascular agents | Cardiovascular disease | Heart attacks | Medical treatment | Morbidity | Clinical outcomes | Myocardial infarction | Risk | Subgroups | Reduction | Motivation | Peptidyl-dipeptidase A | Gangrene | Cardiology | Heart diseases | Heart failure | Hypertension | Stroke | Risk groups | Mortality | Coronary artery | Health risks | Risk reduction | Angina pectoris | Coronary artery disease | Disease control | Patients | Heart rate | Inhibitors | Coronary vessels | Angiotensin | Infarction | Diabetes | Ventricle | Cardiovascular diseases | Health risk assessment | Potassium
Journal Article